BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/17/2020 4:08:25 AM | Browse: 700 | Download: 1423
 |
Received |
|
2019-10-16 13:10 |
 |
Peer-Review Started |
|
2019-10-11 07:45 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2019-12-04 14:27 |
 |
Revised |
|
2019-12-13 13:35 |
 |
Second Decision |
|
2019-12-19 07:50 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2019-12-22 13:31 |
 |
Articles in Press |
|
2019-12-22 13:31 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2019-12-26 02:14 |
 |
Typeset the Manuscript |
|
2020-01-09 01:10 |
 |
Publish the Manuscript Online |
|
2020-01-17 04:08 |
ISSN |
2307-8960 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2020 Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Case Report |
Article Title |
Durable response to pulsatile icotinib for central nervous system metastases from EGFR-mutated non-small cell lung cancer: A case report
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Hui-Ying Li, Yu Xie, Ting-Ting Yu, Yong-Juan Lin and Zhen-Yu Yin |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
the Key Project of Nanjing Health Bureau |
ZKX16031 |
the Healthcare Project of Nanjing Science and Technology Committee |
201715020 |
the Medical Key Science and Technology Development Project of Nanjing |
ZKX18014 |
the Cadre Health Care Project of Jiangsu Province |
BJ18006 |
the Cancer Research Funding of CSCO-Hausen |
Y-HS2019-5 |
|
Corresponding Author |
Zhen-Yu Yin, PhD, Attending Doctor, Department of Geriatric Oncology, Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing 210008, Jiangsu Province, China. lihuiying@njglyy.com |
Key Words |
Non-small cell lung cancer; Central nervous system metastases; EGFR mutation; Pulsatile icotinib; Case report; |
Core Tip |
Central nervous system (CNS) metastases are a catastrophic complication of non-small cell lung cancer (NSCLC) and always accompanied by poor prognosis. We report a patient who was diagnosed with CNS metastases from NSCLC with a targeted mutation in epidermal growth factor receptor. A standard dosage of icotinib (125 mg three times daily) was implemented but ineffective. So pulsatile icotinib (1125 mg every 3 d) was administered. This new strategy for administration resulted in complete remission of neurological symptoms, almost vanished lesions, and longer survival without notable side effects, providing a new alternative for the treatment of CNS metastases. |
Publish Date |
2020-01-17 04:08 |
Citation |
Li HY, Xie Y, Yu TT, Lin YJ, Yin ZY. Durable response to pulsatile icotinib for central nervous system metastases from EGFR-mutated non-small cell lung cancer: A case report. World J Clin Cases 2020; 8(2): 370-376 |
URL |
https://www.wjgnet.com/2307-8960/full/v8/i2/370.htm |
DOI |
https://dx.doi.org/10.12998/wjcc.v8.i2.370 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345